Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Blood Advances|June 23, 2022
Anchoring IgG-degrading enzymes to the surface of platelets selectively neutralizes antiplatelet antibodiesDonald R Lynch, Emily N Stringham, Boya Zhang, et al.
Thrombosis Research|December 9, 2022
Effect of pulmonary embolism response team on advanced therapies administered: The University of Michigan experienceNelish S Ardeshna, Melinda Song, Syed N Hyder, et al.
Bioconjugate Chemistry|February 13, 2018
Ferritin Nanocages with Biologically Orthogonal Conjugation for Vascular Targeting and ImagingMakan Khoshnejad, Colin F Greineder, Katherine W Pulsipher, et al.
Scientific Reports|January 31, 2018
Molecular engineering of antibodies for site-specific covalent conjugation using CRISPR/Cas9Makan Khoshnejad, Jacob S Brenner, William Motley, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 15, 2012
Antioxidant protection by PECAM-targeted delivery of a novel NADPH-oxidase inhibitor to the endothelium in vitro and in vivoElizabeth D Hood, Colin F Greineder, Chandra Dodia, et al.
Advanced Therapeutics|October 6, 2025
Enzyme-Based Synthetic Protein Nanoparticles as Colloidal AntioxidantsAva Mauser, Daniel F Quevedo, Boya Zhang, et al.
Bioconjugate Chemistry|December 5, 2017
Site-Specific Modification of Single-Chain Antibody Fragments for Bioconjugation and Vascular ImmunotargetingColin F Greineder, Carlos H Villa, Landis R Walsh, et al.
Plos One|January 14, 2017
Mechanism of Collaborative Enhancement of Binding of Paired Antibodies to Distinct Epitopes of Platelet Endothelial Cell Adhesion Molecule-1Raisa Kiseleva, Colin F Greineder, Carlos H Villa, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 25, 2024
Affinity targeting of therapeutic proteins to the bone surface-local delivery of sclerostin-neutralizing antibody enhances efficacyBoya Zhang, William Benton Swanson, Margaret Durdan, et al.
Plos One|November 19, 2013
Vascular immunotargeting to endothelial determinant ICAM-1 enables optimal partnering of recombinant scFv-thrombomodulin fusion with endogenous cofactorColin F Greineder, Ann-Marie Chacko, Sergei Zaytsev, et al.
Pageof 7